COMP <GO>
NTRA vs MRK // ENTERPRISE SCALE & MARKET CAP
Natera Inc. (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: NTRA 4
— MRK 9
▲ ENTERPRISE SCALE & MARKET CAP LEADER: MRK
LAST: $414.30 (-4.98%) • MKT CAP: $62.85B
market-cap
$62.85B
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
market-cap
$361.02B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NTRA VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NTRA | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 74.80% | -33.80 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -4.90% | 20.70% | -25.60 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.17% | 3.42% | -3.25 | MRK | /fcf-yield <GO> |
| Operating Margin | -13.40% | 34.30% | -47.70 | MRK | /operating-margins <GO> |
| Net Profit Margin | -9.00% | 28.10% | -37.10 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 35.90% | 1.30% | +34.60 | NTRA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 5.19 | +20.81 | NTRA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.60% | +0.60 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.8 | 56.9 | -0.04 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.09 | 0.92 | +0.17 | NTRA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 18.4x | -0.40 | NTRA | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $62.85B | $361.02B | -$298.17B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NTRA REV | MRK REV | NTRA GROSS % | MRK GROSS % | NTRA FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.31B | $65.01B | 44.0% | 74.8% | $109.1M | $12.36B |
| FY 2024 | $1.70B | $64.17B | 44.0% | 76.3% | $69.2M | $18.10B |
| FY 2023 | $1.08B | $60.12B | 44.0% | 44.0% | -$295.7M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NTRA // BETA 1.09
MRK // BETA 0.92